---
schema_version: "secwatch.filing_event.v1"
accession: "0001093557-25-000050"
form_type: "8-K"
ticker: "DXCM"
cik: "0001093557"
company_name: "DEXCOM INC"
filed_at: "2025-03-10T23:59:59+00:00"
generated_at: "2026-05-25T00:47:33.392938+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# DexCom appoints Renée Galá, Jazz Pharmaceuticals COO, to board

## Summary
- Renée Galá appointed to DexCom board effective March 6, 2025; term expires at the 2025 annual meeting.
- Galá currently serves as President and COO of Jazz Pharmaceuticals, with prior CFO roles at Jazz and Theravance Biopharma.
- Received an initial RSU grant with a fair value of $500,000, vesting annually over three years.
- Board determined Galá qualifies as an independent director under Nasdaq rules.
- Galá also eligible for a pro-rated annual director RSU grant of $56,986 around the 2025 annual meeting.

## SEC filing metadata
- accession: 0001093557-25-000050
- form_type: 8-K
- ticker: DXCM
- cik: 0001093557
- company_name: DEXCOM INC
- filed_at: 2025-03-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1093557/000109355725000050/0001093557-25-000050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1093557/000109355725000050/dxcm-20250306.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001093557-25-000050
- JSON: https://secwatch.observer/filing/0001093557-25-000050.json
- Plain text: https://secwatch.observer/filing/0001093557-25-000050.txt

## Key facts
- Executive change
  Renée Galá was appointed as director at DEXCOM INC.
  - Action: appointed
  - Role: director
  source text: On March 6, 2025, the Board of Directors (the “Board”) of DexCom, Inc. (“Dexcom”) increased the size of the Board to eleven directors and appointed Renée Galá as a director effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1093557/000109355725000050/0001093557-25-000050-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.